Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boehringer Ingelheim Vetmedica endorses BVDv testing

Boehringer Ingelheim Vetmedica endorses BVDv testing

7th September 2010

Boehringer Ingelheim Vetmedica has highlighted the benefits of testing calves for bovine viral diarrhoea virus (BVDv) in order to prevent the spread of the disease.

Dr Joe Campbell, professional service veterinarian with Boehringer Ingelheim Vetmedica, stated that biosecurity initiatives to screen animals for persistently-infected (PI) specimens are becoming increasingly important.

According to the firm, which manufactures the BVDv vaccine Express FP, the disease is a harmful and costly condition which remains prevalent despite efforts to combat it.

Dr Campbell called for a wider move towards routine testing of bulls, dams and calves, with culling taking place when PI-positive animals are identified.

He explained: "A dam can test negative, but still have a PI calf. Testing the calves is critical. If the calf is positive, then the dam should be tested."

In July 2010, Boehringer Ingelheim Vetmedica was granted approval from the EU Commission to launch FLEXcombo, a new pig vaccine therapy which combines the company's Ingelvac CircoFLEX and Ingelvac MycoFLEX products.ADNFCR-8000103-ID-800054911-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.